chiniofon has been researched along with Biliary-Tract-Diseases* in 2 studies
2 other study(ies) available for chiniofon and Biliary-Tract-Diseases
| Article | Year |
|---|---|
[Antibiotic and chemopreparation sensitivity of the microflora isolated from the bile in inflammatory diseases of the biliary excretory system].
The study of sensitivity to some antibiotics and chemotherapeutics of 250 cultures of the main causative agents of the inflammatory diseases of the bile secretion system, i. e. Coli bacteria, Proteus, Ps. aeruginosa and Staphylococcus showed that the above microorganisms were in most cases highly resistant to the antibacterial drugs widely used in the clinical practice. The exclusion presented the drugs of the aminoglycoside group and especially gentamycin which had the highest activity. The analysis of multiple resistance showed that 96 per cent of the strains were resistant to 5 and more antibacterial drugs. Topics: Anti-Bacterial Agents; Bile; Biliary Tract Diseases; Drug Resistance, Microbial; Escherichia coli; Furazolidone; Humans; Hydantoins; Hydroxyquinolines; Microbial Sensitivity Tests; Nalidixic Acid; Nitro Compounds; Proteus; Pseudomonas aeruginosa; Staphylococcus | 1976 |
99mTc-bioquin-7CA, a potential new hepatobiliary scanning agent.
The complex 99mTc-Sn-8-hydroxyquinoline-7-carboxylate (99mTc-bioquin-7CA) was investigated in animals as a potential hepatobiliary scanning agent. Following intravenous injection, the complex was found to localize in the liver rapidly and in the gallbladder in 5--15 min; after 15 min it was excreted into the biliary tract with a high degree of specificity. Urinary excretion was negligible, reducing scan interference from the kidneys. Distribution studies in mice compared well withe localization of activity observed in rabbit scans. Preparation of the complex was rapid and simple; stannous ion was used as the reducing agent. Topics: Biliary Tract Diseases; Hydroxyquinolines; Liver Diseases; Oxyquinoline; Technetium | 1976 |